Back to Top
Go Back
Journal Photo for Journal of Psychiatry and Neuroscience
Peer reviewed only Open Access

Journal of Psychiatry and Neuroscience (JPN)

Publisher : CMA Impact Inc.
psychiatry neuroscience etiology
e-ISSN 1488-2434
p-ISSN 1180-4882
Issue Frequency Monthly
Impact Factor 4.1
Est. Year 1975
Mobile 8669719171
Country Afghanistan
Language English
APC YES
Impact Factor Assignee Google Scholar
Email jpn@cma.ca

Journal Descriptions

The Journal of Psychiatry & Neuroscience (JPN) publishes papers at the intersection of psychiatry and neuroscience that advance our understanding of the neural mechanisms involved in the etiology and treatment of psychiatric disorders. This includes studies on patients with psychiatric disorders, healthy humans, and experimental animals as well as studies in vitro. Original research articles, including clinical trials with a mechanistic component, and review papers will be considered. JPN is an open access journal. All articles published are available free of charge on this website as well as on PubMed Central. JPN is owned by CMA Impact Inc., a subsidiary of the Canadian Medical Association. A high-quality scientific journal could not be produced without the anonymous, unpaid and often inadequately appreciated work of its reviewers. The editors and staff of the Journal of Psychiatry & Neuroscience thank everyone who reviewed submissions to the journal in 2022. View the 2022 Reviewer list.

Journal of Psychiatry and Neuroscience (JPN) is :-

  • International, Peer-Reviewed, Open Access, Refereed, psychiatry, neuroscience, etiology, treatment of psychiatric disorders, healthy humans, experimental animals , Online or Print , Monthly Journal

  • UGC Approved, ISSN Approved: P-ISSN P-ISSN: 1180-4882, E-ISSN: 1488-2434, Established: 1975, Impact Factor: 4.1
  • Does Not Provide Crossref DOI
  • Indexed in: Scopus, WoS, PubMed

  • Not indexed in DOAJ, UGC CARE

Indexing

Publications of JPN

Peer Briken November, 2015
To date there are few treatment options to reduce high sexual drive or sexual urges in paraphilic patients with a risk for sexual offending. Pharmacological therapy aims to reduce sexual dri...